{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T21:39:51Z","timestamp":1773092391724,"version":"3.50.1"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T00:00:00Z","timestamp":1691366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T00:00:00Z","timestamp":1691366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["838786"],"award-info":[{"award-number":["838786"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RR160005"],"award-info":[{"award-number":["RR160005"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["U01CA142565"],"award-info":[{"award-number":["U01CA142565"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["U01CA174706"],"award-info":[{"award-number":["U01CA174706"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01CA186193"],"award-info":[{"award-number":["R01CA186193"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["U24CA226110"],"award-info":[{"award-number":["U24CA226110"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R50CA243783"],"award-info":[{"award-number":["R50CA243783"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["U01CA253540"],"award-info":[{"award-number":["U01CA253540"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004769","name":"Universit\u00e0 degli Studi di Pavia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004769","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Engineering with Computers"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Neoadjuvant chemotherapy (NAC) is a standard-of-care treatment for locally advanced triple negative breast cancer (TNBC) before surgery. The early assessment of TNBC response to NAC would enable an oncologist to adapt the therapeutic plan of a non-responding patient, thereby improving treatment outcomes while preventing unnecessary toxicities. To this end, a promising approach consists of obtaining in silico personalized forecasts of tumor response to NAC via computer simulation of mechanistic models constrained with patient-specific magnetic resonance imaging (MRI) data acquired early during NAC. Here, we present a new mechanistic model of TNBC growth and response to NAC, including an explicit description of drug pharmacodynamics and pharmacokinetics. As longitudinal in vivo MRI data for model calibration is limited, we perform a sensitivity analysis to identify the model mechanisms driving the response to two NAC drug combinations: doxorubicin with cyclophosphamide, and paclitaxel with carboplatin. The model parameter space is constructed by combining patient-specific MRI-based in silico parameter estimates and in vitro measurements of pharmacodynamic parameters obtained using time-resolved microscopy assays of several TNBC lines. The sensitivity analysis is run in two MRI-based scenarios corresponding to a well-perfused and a poorly perfused tumor. Out of the 15 parameters considered herein, only the baseline tumor cell net proliferation rate along with the maximum concentrations and effects of doxorubicin, carboplatin, and paclitaxel exhibit a relevant impact on model forecasts (total effect index, <jats:inline-formula><jats:alternatives><jats:tex-math>$$S_{T}$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                  <mml:msub>\n                    <mml:mi>S<\/mml:mi>\n                    <mml:mi>T<\/mml:mi>\n                  <\/mml:msub>\n                <\/mml:math><\/jats:alternatives><\/jats:inline-formula>0.1). These results dramatically limit the number of parameters that require in vivo MRI-constrained calibration, thereby facilitating the clinical application of our model.<\/jats:p>","DOI":"10.1007\/s00366-023-01873-0","type":"journal-article","created":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T04:02:06Z","timestamp":1691380926000},"page":"1469-1499","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A global sensitivity analysis of a mechanistic model of neoadjuvant chemotherapy for triple negative breast cancer constrained by in vitro and in vivo imaging data"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9090-190X","authenticated-orcid":false,"given":"Guillermo","family":"Lorenzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela M.","family":"Jarrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian T.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie C.","family":"DiCarlo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Virostko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vito","family":"Quaranta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darren R.","family":"Tyson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas E.","family":"Yankeelov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,7]]},"reference":[{"issue":"4","key":"1873_CR1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/jso.21446","volume":"101","author":"SV Liu","year":"2010","unstructured":"Liu SV, Melstrom L, Yao K, Russell CA, Sener SF (2010) Neoadjuvant therapy for breast cancer. J Surg Oncol 101(4):283\u2013291","journal-title":"J Surg Oncol"},{"issue":"1","key":"1873_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1146\/annurev-med-051413-024741","volume":"66","author":"D Zardavas","year":"2015","unstructured":"Zardavas D, Piccart M (2015) Neoadjuvant therapy for breast cancer. Annu Rev Med 66(1):31\u201348","journal-title":"Annu Rev Med"},{"issue":"3","key":"1873_CR3","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","volume":"321","author":"AG Waks","year":"2019","unstructured":"Waks AG, Winer EP (2019) Breast cancer treatment: A review. JAMA 321(3):288\u2013300","journal-title":"JAMA"},{"issue":"6","key":"1873_CR4","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nrclinonc.2015.63","volume":"12","author":"TA King","year":"2015","unstructured":"King TA, Morrow M (2015) Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy. Nat Rev Clin Oncol 12(6):335\u2013343","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"1873_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S1470-2045(17)30777-5","volume":"19","author":"B Asselain","year":"2018","unstructured":"Asselain B, Barlow W, Bartlett J, Bergh J, Bergsten-Nordstr\u00f6m E, Bliss J, Boccardo F, Boddington C, Bogaerts J, Bonadonna G, Bradley R, Brain E, Braybrooke J, Broet P, Bryant J, Burrett J, Cameron D, Clarke M, Coates A, Coleman R, Coombes RC, Correa C, Costantino J, Cuzick J, Danforth D, Davidson N, Davies C, Davies L, Di Leo A, Dodwell D, Dowsett M, Duane F, Evans V, Ewertz M, Fisher B, Forbes J, Ford L, Gazet JC, Gelber R, Gettins L, Gianni L, Gnant M, Godwin J, Goldhirsch A, Goodwin P, Gray R, Hayes D, Hill C, Ingle J, Jagsi R, Jakesz R, James S, Janni W, Liu H, Liu Z, Lohrisch C, Loibl S, MacKinnon L, Makris A, Mamounas E, Mannu G, Mart\u00edn M, Mathoulin S, Mauriac L, McGale P, McHugh T, Morris P, Mukai H, Norton L, Ohashi Y, Olivotto I, Paik S, Pan H, Peto R, Piccart M, Pierce L, Poortmans P, Powles T, Pritchard K, Ragaz J, Raina V, Ravdin P, Read S, Regan M, Robertson J, Rutgers E, Scholl S, Slamon D, S\u00f6lkner L, Sparano J, Steinberg S, Sutcliffe R, Swain S, Taylor C, Tutt A, Valagussa P, van de Velde C, van der Hage J, viale G, von Minckwitz G, Wang Y, Wang Z, Wang X, Whelan T, Wilcken N, Winer E, Wolmark N, Wood W, Zambetti M, Zujewski JA (2018) Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. Lancet Oncol. 19(1):27\u201339","journal-title":"Lancet Oncol."},{"issue":"1","key":"1873_CR6","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1245\/s10434-020-08593-5","volume":"28","author":"O Petruolo","year":"2021","unstructured":"Petruolo O, Sevilimedu V, Montagna G, Le T, Morrow M, Barrio AV (2021) How often does modern neoadjuvant chemotherapy downstage patients to breast-conserving surgery? Ann Surg Oncol 28(1):287\u2013294","journal-title":"Ann Surg Oncol"},{"issue":"15","key":"1873_CR7","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","volume":"30","author":"G von Minckwitz","year":"2012","unstructured":"von Minckwitz G, Untch M, Blohmer JU, Costa SD, Eidtmann H, Fasching PA, Gerber B, Eiermann W, Hilfrich J, Huober J, Jackisch C, Kaufmann M, Konecny GE, Denkert C, Nekljudova V, Mehta K, Loibl S (2012) Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. J Clin Oncol 30(15):1796\u20131804","journal-title":"J Clin Oncol"},{"issue":"12","key":"1873_CR8","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1158\/1078-0432.CCR-19-3492","volume":"26","author":"LM Spring","year":"2020","unstructured":"Spring LM, Fell G, Arfe A, Sharma C, Greenup R, Reynolds KL, Smith BL, Alexander B, Moy B, Isakoff SJ, Parmigiani G, Trippa L, Bardia A (2020) Pathologic complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: A comprehensive meta-analysis. Clin Cancer Res 26(12):2838\u20132848","journal-title":"Clin Cancer Res"},{"key":"1873_CR9","doi-asserted-by":"crossref","unstructured":"Yau C, Osdoit M, van der Noordaa M, Shad S, Wei J, de Croze D, Hamy A.S, La\u00e9 M, Reyal F, Sonke G.S, Steenbruggen T.G, van Seijen M, Wesseling J, Mart\u00edn M, del Monte-Mill\u00e1n M, L\u00f3pez-Tarruella S, Adamson K, Albain K.S, Asare A.L, Asare S.M, Balassanian R, Beckwith H, Berry S.M, Berry D.A, Boughey J.C, Buxton M.B, Chen Y.Y, Chen B, Chien A.J, Chui S.Y, Clark A.S, Clennell J.L, Datnow B, DeMichele A.M, Duan X, Edmiston K.K, Elias A.D, Ellis E.D, Esserman L.L, Euhus D.M, Fadare O, Fan F, Feldman M.D, Forero-Torres A, Haley B.B, Han H.S, Harada S, Haugen P, Helsten T, Hirst G.L, Hylton N.M, Isaacs C, Kemmer K, Khan Q.J, Khazai L, Klein M.E, Krings G, Lang J.E, LeBeau L.G, Leyland-Jones B, Liu M.C, Lo S, Lu J, Magliocco A, Matthews J.B, Melisko M.E, Mhawech-Fauceglia P, Moulder S.L, Murthy R.K, Nanda R, Northfelt D.W, Ocal I.T, Olopade O, Pambuccian S, Paoloni M, Park J.W, Parker B.A, Perlmutter J, Peterson G, Pusztai L, Rendi M, Rugo H.S, Sahoo S, Sams S, Sanil A, Sattar H, Schwab R.B, Singhrao R, Steeg K, Stringer-Reasor E, Symmans W.F, Tawfik O, Tripathy D, Troxell M.L, van\u2019t Veer L.J, Venters S.J, Vinh T, Viscusi R.K, Wallace A.M, Wei S, Wilson A, Yau C, Yee D, Zeck J.C, Boughey J.C, Goetz M.P, Hoskin T, Gould R, Valero V, Edge S.B, Abraham J.E, Bartlett J.M.S, Caldas C, Dunn J, Earl H, Hayward L, Hiller L, Provenzano E, Sammut S.J, Thomas J.S, Cameron D, Graham A, Hall P, Mackintosh L, Fan F, Godwin A.K, Schwensen K, Sharma P, DeMichele A.M, Cole K, Pusztai L, Kim M.O, van \u2019t Veer L.J, Esserman L.J, Symmans W.F (2022) Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients. Lancet Oncol 23(1):149\u2013160","DOI":"10.1016\/S1470-2045(21)00589-1"},{"issue":"1","key":"1873_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/clpt.2009.68","volume":"86","author":"A Barker","year":"2009","unstructured":"Barker A, Sigman C, Kelloff G, Hylton N, Berry D, Esserman L (2009) I-SPY 2: An adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy. Clin Pharmacol Ther 86(1):97\u2013100","journal-title":"Clin Pharmacol Ther"},{"issue":"29","key":"1873_CR11","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.1200\/JCO.2012.45.0940","volume":"31","author":"G von Minckwitz","year":"2013","unstructured":"von Minckwitz G, Blohmer JU, Costa SD, Denkert C, Eidtmann H, Eiermann W, Gerber B, Hanusch C, Hilfrich J, Huober J, Jackisch C, Kaufmann M, K\u00fcmmel S, Paepke S, Schneeweiss A, Untch M, Zahm DM, Mehta K, Loibl S (2013) Response-guided neoadjuvant chemotherapy for breast cancer. J Clin Oncol 31(29):3623\u20133630","journal-title":"J Clin Oncol"},{"issue":"9","key":"1873_CR12","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.3390\/cancers12092392","volume":"12","author":"GK Gupta","year":"2020","unstructured":"Gupta GK, Collier AL, Lee D, Hoefer RA, Zheleva V, Siewertsz van Reesema LL, Tang-Tan AM, Guye ML, Chang DZ, Winston JS, Samli B, Jansen RJ, Petricoin EF, Goetz MP, Bear HD, Tang AH (2020) Perspectives on triple-negative breast cancer: current treatment strategies, unmet needs, and potential targets for future therapies. Cancers 12(9):2392","journal-title":"Cancers"},{"key":"1873_CR13","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1016\/j.breast.2017.06.022","volume":"34","author":"J Veeraraghavan","year":"2017","unstructured":"Veeraraghavan J, De Angelis C, Reis-Filho JS, Pascual T, Prat A, Rimawi MF, Osborne CK, Schiff R (2017) De-escalation of treatment in HER2-positive breast cancer: determinants of response and mechanisms of resistance. The Breast 34:S19\u2013S26","journal-title":"The Breast"},{"issue":"6","key":"1873_CR14","doi-asserted-by":"publisher","first-page":"723","DOI":"10.6004\/jnccn.2022.7016","volume":"20","author":"LM Spring","year":"2022","unstructured":"Spring LM, Bar Y, Isakoff SJ (2022) The evolving role of neoadjuvant therapy for operable breast cancer. J Natl Compr Canc Netw 20(6):723\u2013734","journal-title":"J Natl Compr Canc Netw"},{"issue":"8","key":"1873_CR15","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.3390\/cancers14081856","volume":"14","author":"RK Gupta","year":"2022","unstructured":"Gupta RK, Roy AM, Gupta A, Takabe K, Dhakal A, Opyrchal M, Kalinski P, Gandhi S (2022) Systemic therapy de-escalation in early-stage triple-negative breast cancer: Dawn of a new era? Cancers 14(8):1856","journal-title":"Cancers"},{"issue":"1","key":"1873_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.annonc.2019.10.012","volume":"31","author":"J Heil","year":"2020","unstructured":"Heil J, Kuerer H, Pfob A, Rauch G, Sinn H, Golatta M, Liefers G, VranckenPeeters M (2020) Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges. Ann Oncol 31(1):61\u201371","journal-title":"Ann Oncol"},{"issue":"2","key":"1873_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"E Eisenhauer","year":"2009","unstructured":"Eisenhauer E, Therasse P, Bogaerts J, Schwartz L, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J (2009) New response evaluation criteria in solid tumours: Revised RECIST guideline(version 1.1). Eur J Cancer 45(2):228\u2013247","journal-title":"Eur J Cancer"},{"issue":"3","key":"1873_CR18","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1148\/radiol.12110748","volume":"263","author":"NM Hylton","year":"2012","unstructured":"Hylton NM, Blume JD, Bernreuter WK, Pisano ED, Rosen MA, Morris EA, Weatherall PT, Lehman CD, Newstead GM, Polin S, Marques HS, Esserman LJ, Schnall MD (2012) Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy - Results from ACRIN 6657\/I-SPY TRIAL. Radiology 263(3):663\u2013672","journal-title":"Radiology"},{"issue":"8","key":"1873_CR19","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nrclinonc.2016.1","volume":"13","author":"F Penault-Llorca","year":"2016","unstructured":"Penault-Llorca F, Radosevic-Robin N (2016) Biomarkers of residual disease after neoadjuvant therapy for breast cancer. Nat Rev Clin Oncol 13(8):487\u2013503","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"1873_CR20","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1186\/bcr1508","volume":"8","author":"R Burcombe","year":"2006","unstructured":"Burcombe R, Wilson GD, Dowsett M, Khan I, Richman PI, Daley F, Detre S, Makris A (2006) Evaluation of Ki-67 proliferation and apoptotic index before, during and after neoadjuvant chemotherapy for primary breast cancer. Breast Cancer Res 8(3):R31","journal-title":"Breast Cancer Res"},{"key":"1873_CR21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.semcancer.2017.08.010","volume":"52","author":"A Nicolini","year":"2018","unstructured":"Nicolini A, Ferrari P, Duffy MJ (2018) Prognostic and predictive biomarkers in breast cancer: Past, present and future. Semin Cancer Biol 52:56\u201373","journal-title":"Semin Cancer Biol"},{"key":"1873_CR22","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ejca.2017.01.017","volume":"75","author":"M Duffy","year":"2017","unstructured":"Duffy M, Harbeck N, Nap M, Molina R, Nicolini A, Senkus E, Cardoso F (2017) Clinical use of biomarkers in breast cancer: updated guidelines from the European Group on Tumor Markers (EGTM). Eur J Cancer 75:284\u2013298","journal-title":"Eur J Cancer"},{"issue":"7","key":"1873_CR23","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.mri.2005.11.005","volume":"24","author":"MD Pickles","year":"2006","unstructured":"Pickles MD, Gibbs P, Lowry M, Turnbull LW (2006) Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging 24(7):843\u2013847","journal-title":"Magn Reson Imaging"},{"issue":"1","key":"1873_CR24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.tranon.2015.11.016","volume":"9","author":"A Tudorica","year":"2016","unstructured":"Tudorica A, Oh KY, Chui SYC, Roy N, Troxell ML, Naik A, Kemmer KA, Chen Y, Holtorf ML, Afzal A, Springer CS, Li X, Huang W (2016) Early prediction and evaluation of breast cancer response to neoadjuvant chemotherapy using quantitative DCE-MRI. Trans. Oncol. 9(1):8\u201317","journal-title":"Trans. Oncol."},{"issue":"12","key":"1873_CR25","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1136\/jcp.2006.045377","volume":"60","author":"EA Rakha","year":"2007","unstructured":"Rakha EA, Ellis IO (2007) An overview of assessment of prognostic and predictive factors in breast cancer needle core biopsy specimens. J Clin Pathol 60(12):1300\u20131306","journal-title":"J Clin Pathol"},{"issue":"3","key":"1873_CR26","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s10549-018-05119-2","volume":"174","author":"S Robertson","year":"2019","unstructured":"Robertson S, R\u00f6nnlund C, de Boniface J, Hartman J (2019) Re-testing of predictive biomarkers on surgical breast cancer specimens is clinically relevant. Breast Cancer Res Treat 174(3):795\u2013805","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"1873_CR27","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s10549-020-06075-6","volume":"186","author":"P Qi","year":"2021","unstructured":"Qi P, Yang Y, Bai Q, Xue T, Ren M, Yao Q, Yang W, Zhou X (2021) Concordance of the 21-gene assay between core needle biopsy and resection specimens in early breast cancer patients. Breast Cancer Res Treat 186(2):327\u2013342","journal-title":"Breast Cancer Res Treat"},{"issue":"187","key":"1873_CR28","doi-asserted-by":"publisher","first-page":"187ps9","DOI":"10.1126\/scitranslmed.3005686","volume":"5","author":"TE Yankeelov","year":"2013","unstructured":"Yankeelov TE, Atuegwu N, Hormuth DA, Weis JA, Barnes SL, Miga MI, Rericha EC, Quaranta V (2013) Clinically relevant modeling of tumor growth and treatment response. Sci. Transl. Med. 5(187):187ps9","journal-title":"Sci. Transl. Med."},{"key":"1873_CR29","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev-bioeng-062117-121105","volume":"22","author":"A Mang","year":"2020","unstructured":"Mang A, Bakas S, Subramanian S, Davatzikos C, Biros G (2020) Integrated biophysical modeling and image analysis: application to neuro-oncology. Annu Rev Biomed Eng 22:309\u2013341","journal-title":"Annu Rev Biomed Eng"},{"key":"1873_CR30","doi-asserted-by":"crossref","unstructured":"Lorenzo G, Hormuth II DA, Jarrett AM, Lima EA, Subramanian S, Biros G, Oden JT, Hughes TJ, Yankeelov TE (2022) Quantitative in vivo imaging to enable tumor forecasting and treatment optimization. In: Balaz I, Adamatzky A (eds) Cancer, complexity, computation. Springer, Berlin","DOI":"10.1007\/978-3-031-04379-6_3"},{"issue":"23","key":"1873_CR31","doi-asserted-by":"publisher","first-page":"9133","DOI":"10.1158\/0008-5472.CAN-08-3863","volume":"69","author":"CH Wang","year":"2009","unstructured":"Wang CH, Rockhill JK, Mrugala M, Peacock DL, Lai A, Jusenius K, Wardlaw JM, Cloughesy T, Spence AM, Rockne R, Alvord EC, Swanson KR (2009) Prognostic significance of growth kinetics in newly diagnosed glioblastomas revealed by combining serial imaging with a novel biomathematical model. Cancer Res 69(23):9133\u20139140","journal-title":"Cancer Res"},{"issue":"8","key":"1873_CR32","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1109\/TMI.2019.2902044","volume":"38","author":"J Lipkov\u00e1","year":"2019","unstructured":"Lipkov\u00e1 J, Angelikopoulos P, Wu S, Alberts E, Wiestler B, Diehl C, Preibisch C, Pyka T, Combs SE, Hadjidoukas P, Van Leemput K, Koumoutsakos P, Lowengrub J, Menze B (2019) Personalized radiotherapy design for glioblastoma: integrating mathematical tumor models, multimodal scans, and Bayesian inference. IEEE Trans. Med. Imag. 38(8):1875\u20131884","journal-title":"IEEE Trans. Med. Imag."},{"issue":"12 Supplement","key":"1873_CR33","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.1158\/1538-7445.AM2022-5064","volume":"82","author":"G Lorenzo","year":"2022","unstructured":"Lorenzo G, Heiselman JS, Liss MA, Miga MI, Gomez H, Yankeelov TE, Hughes TJ, Reali A (2022) Abstract 5064: patient-specific forecasting of prostate cancer growth during active surveillance using an imaging-informed mechanistic model. Cancer Res 82(12 Supplement):5064","journal-title":"Cancer Res"},{"key":"1873_CR34","doi-asserted-by":"publisher","first-page":"8520","DOI":"10.1038\/s41598-021-87887-4","volume":"11","author":"DA Hormuth","year":"2021","unstructured":"Hormuth DA, Al Feghali KA, Elliott AM, Yankeelov TE, Chung C (2021) Image-based personalization of computational models for predicting response of high-grade glioma to chemoradiation. Sci Rep 11:8520","journal-title":"Sci Rep"},{"issue":"1","key":"1873_CR35","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1109\/TBME.2012.2222027","volume":"60","author":"X Chen","year":"2012","unstructured":"Chen X, Summers RM, Yoa J (2012) Kidney tumor growth prediction by coupling reaction\u2013diffusion and biomechanical model. IEEE Trans Biomed Eng 60(1):169\u2013173","journal-title":"IEEE Trans Biomed Eng"},{"issue":"1","key":"1873_CR36","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1109\/TMI.2016.2597313","volume":"36","author":"KCL Wong","year":"2017","unstructured":"Wong KCL, Summers RM, Kebebew E, Yoa J (2017) Pancreatic tumor growth prediction with elastic-growth decomposition, image-derived motion, and FDM-FEM coupling. IEEE Trans Med Imag 36(1):111\u2013123","journal-title":"IEEE Trans Med Imag"},{"issue":"3","key":"1873_CR37","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.media.2014.02.005","volume":"18","author":"Y Liu","year":"2014","unstructured":"Liu Y, Sadowski SM, Weisbrod AB, Kebebew E, Summers RM, Yao J (2014) Patient specific tumor growth prediction using multimodal images. Med Image Anal 18(3):555\u2013566","journal-title":"Med Image Anal"},{"key":"1873_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cma.2020.113590","volume":"374","author":"M Tajdari","year":"2021","unstructured":"Tajdari M, Pawar A, Li H, Tajdari F, Maqsood A, Cleary E, Saha S, Zhang YJ, Sarwark JF, Liu WK (2021) Image-based modelling for adolescent idiopathic scoliosis: mechanistic machine learning analysis and prediction. Comput Methods Appl Mech Eng 374:113590","journal-title":"Comput Methods Appl Mech Eng"},{"issue":"5","key":"1873_CR39","doi-asserted-by":"publisher","first-page":"4061","DOI":"10.1007\/s00366-022-01742-2","volume":"38","author":"M Tajdari","year":"2022","unstructured":"Tajdari M, Tajdari F, Shirzadian P, Pawar A, Wardak M, Saha S, Park C, Huysmans T, Song Y, Zhang YJ et al (2022) Next-generation prognosis framework for pediatric spinal deformities using bio-informed deep learning networks. Eng Comput 38(5):4061\u20134084","journal-title":"Eng Comput"},{"key":"1873_CR40","doi-asserted-by":"crossref","unstructured":"Sch\u00e4fer A, Peirlinck M, Linka K, Kuhl ETA (2021) Bayesian physics-based modeling of tau propagation in Alzheimer\u2019s disease. Front Physiol 12:702975","DOI":"10.3389\/fphys.2021.702975"},{"issue":"6","key":"1873_CR41","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.jcmg.2018.01.023","volume":"12","author":"JM Lee","year":"2019","unstructured":"Lee JM, Choi G, Koo BK, Hwang D, Park J, Zhang J, Kim KJ, Tong Y, Kim HJ, Grady L, Doh JH, Nam CW, Shin ES, Cho YS, Choi SY, Chun EJ, Choi JH, N\u00f8rgaard BL, Christiansen EH, Niemen K, Otake H, Penicka M, de Bruyne B, Kubo T, Akasaka T, Narula J, Douglas PS, Taylor CA, Kim HS (2019) Identification of high-risk plaques destined to cause acute coronary syndrome using coronary computed tomographic angiography and computational fluid dynamics. JACC Cardiovasc Imaging 12(6):1032\u20131043","journal-title":"JACC Cardiovasc Imaging"},{"key":"1873_CR42","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.compfluid.2018.06.002","volume":"179","author":"R Romarowski","year":"2019","unstructured":"Romarowski R, Faggiano E, Conti M, Reali A, Morganti S, Auricchio F (2019) A novel computational framework to predict patient-specific hemodynamics after TEVAR: integration of structural and fluid-dynamics analysis by image elaboration. Comput Fluids 179:806\u2013819","journal-title":"Comput Fluids"},{"key":"1873_CR43","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.bone.2018.02.011","volume":"110","author":"A Sternheim","year":"2018","unstructured":"Sternheim A, Giladi O, Gortzak Y, Drexler M, Salai M, Trabelsi N, Milgrom C, Yosibash Z (2018) Pathological fracture risk assessment in patients with femoral metastases using CT-based finite element methods. A retrospective clinical study. Bone 110:215\u2013220","journal-title":"Bone"},{"issue":"10","key":"1873_CR44","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/aac040","volume":"63","author":"AM Jarrett","year":"2018","unstructured":"Jarrett AM, Hormuth DA, Barnes SL, Feng X, Huang W, Yankeelov TE (2018) Incorporating drug delivery into an imaging-driven, mechanics-coupled reaction diffusion model for predicting the response of breast cancer to neoadjuvant chemotherapy: theory and preliminary clinical results. Phys Med Biol 63(10):105015","journal-title":"Phys Med Biol"},{"issue":"12","key":"1873_CR45","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.neo.2020.10.011","volume":"22","author":"AM Jarrett","year":"2020","unstructured":"Jarrett AM, Hormuth DA, Wu C, Kazerouni AS, Ekrut DA, Virostko J, Sorace AG, DiCarlo JC, Kowalski J, Patt D, Goodgame B, Avery S, Yankeelov TE (2020) Evaluating patient-specific neoadjuvant regimens for breast cancer via a mathematical model constrained by quantitative magnetic resonance imaging data. Neoplasia 22(12):820\u2013830","journal-title":"Neoplasia"},{"issue":"18","key":"1873_CR46","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1158\/0008-5472.CAN-22-1329","volume":"82","author":"C Wu","year":"2022","unstructured":"Wu C, Jarrett AM, Zhou Z, Elshafeey N, Adrada BE, Candelaria RP, Mohamed RM, Boge M, Huo L, White JB, Tripathy D, Valero V, Litton JK, Yam C, Son JB, Ma J, Rauch GM, Yankeelov TE (2022) MRI-based digital models forecast patient-specific treatment responses to neoadjuvant chemotherapy in triple-negative breast cancer. Cancer Res 82(18):3394\u20133404","journal-title":"Cancer Res"},{"issue":"11","key":"1873_CR47","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.1038\/s41596-021-00617-y","volume":"16","author":"AM Jarrett","year":"2021","unstructured":"Jarrett AM, Kazerouni AS, Wu C, Virostko J, Sorace AG, DiCarlo JC, Hormuth DA, Ekrut DA, Patt D, Goodgame B, Avery S, Yankeelov TE (2021) Quantitative magnetic resonance imaging and tumor forecasting of breast cancer patients in the community setting. Nat Protoc 16(11):5309\u20135338","journal-title":"Nat Protoc"},{"issue":"11","key":"1873_CR48","doi-asserted-by":"publisher","first-page":"3334","DOI":"10.1109\/TBME.2022.3168402","volume":"69","author":"C Wu","year":"2022","unstructured":"Wu C, Hormuth D, Lorenzo G, Jarrett A, Pineda F, Howard FM, Karczmar G, Yankeelov TE (2022) Towards patient-specific optimization of neoadjuvant treatment protocols for breast cancer based on image-guided fluid dynamics. IEEE Trans Biomed Eng 69(11):3334\u20133344","journal-title":"IEEE Trans Biomed Eng"},{"issue":"12","key":"1873_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101807","volume":"23","author":"AS Kazerouni","year":"2020","unstructured":"Kazerouni AS, Gadde M, Gardner A, Hormuth DA, Jarrett AM, Johnson KE, Lima EAF, Lorenzo G, Phillips C, Brock A, Yankeelov TE (2020) Integrating quantitative assays with biologically based mathematical modeling for predictive oncology. iScience 23(12):101807","journal-title":"iScience"},{"key":"1873_CR50","doi-asserted-by":"crossref","unstructured":"Saltelli A, Ratto M, Andres T, Campolongo F, Cariboni J, Gatelli D, Saisana M, Tarantola S (2008) Global sensitivity analysis: the primer. John Wiley & Sons","DOI":"10.1002\/9780470725184"},{"issue":"1","key":"1873_CR51","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/BF00666492","volume":"34","author":"W Zoli","year":"1995","unstructured":"Zoli W, Flamigni A, Frassineti GL, Bajorko P, De Paola F, Milandri C, Amadori D, Gasperi-Campani A (1995) in vitro activity of taxol and taxotere in comparison with doxorubicin and cisplatin on primary cell cultures of human breast cancers. Breast Cancer Res Treat 34(1):63\u201369","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"1873_CR52","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.cell.2018.03.041","volume":"173","author":"C Kim","year":"2018","unstructured":"Kim C, Gao R, Sei E, Brandt R, Hartman J, Hatschek T, Crosetto N, Foukakis T, Navin NE (2018) Chemoresistance evolution in triple-negative breast cancer delineated by single-cell sequencing. Cell 173(4):879-893.e13","journal-title":"Cell"},{"issue":"3","key":"1873_CR53","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1158\/1078-0432.CCR-05-1447","volume":"12","author":"HK Dressman","year":"2006","unstructured":"Dressman HK, Hans C, Bild A, Olson JA, Rosen E, Marcom PK, Liotcheva VB, Jones EL, Vujaskovic Z, Marks J, Dewhirst MW, West M, Nevins JR, Blackwell K (2006) Gene expression profiles of multiple breast cancer phenotypes and response to neoadjuvant chemotherapy. Clin Cancer Res 12(3):819\u2013826","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1873_CR54","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1158\/2159-8290.CD-13-0286","volume":"4","author":"JM Balko","year":"2014","unstructured":"Balko JM, Giltnane JM, Wang K, Schwarz LJ, Young CD, Cook RS, Owens P, Sanders ME, Kuba MG, S\u00e1nchez V, Kurupi R, Moore PD, Pinto JA, Doimi FD, G\u00f3mez H, Horiuchi D, Goga A, Lehmann BD, Bauer JA, Pietenpol JA, Ross JS, Palmer GA, Yelensky R, Cronin M, Miller VA, Stephens PJ, Arteaga CL (2014) Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets. Cancer Discov 4(2):232\u2013245","journal-title":"Cancer Discov"},{"issue":"9","key":"1873_CR55","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/nrm1979","volume":"7","author":"R Pepperkok","year":"2006","unstructured":"Pepperkok R, Ellenberg J (2006) High-throughput fluorescence microscopy for systems biology. Nat Rev Mol Cell Biol 7(9):690\u2013696","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"1873_CR56","doi-asserted-by":"publisher","first-page":"5725","DOI":"10.1038\/s41598-017-05902-z","volume":"7","author":"MT McKenna","year":"2017","unstructured":"McKenna MT, Weis JA, Barnes SL, Tyson DR, Miga MI, Quaranta V, Yankeelov TE (2017) A predictive mathematical modeling approach for the study of doxorubicin treatment in triple negative breast cancer. Sci Rep 7(1):5725","journal-title":"Sci Rep"},{"issue":"2","key":"1873_CR57","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cels.2019.01.003","volume":"8","author":"CT Meyer","year":"2019","unstructured":"Meyer CT, Wooten DJ, Paudel BB, Bauer J, Hardeman KN, Westover D, Lovly CM, Harris LA, Tyson DR, Quaranta V (2019) Quantifying drug combination synergy along potency and efficacy axes. Cell Syst 8(2):97-108.e16","journal-title":"Cell Syst"},{"issue":"3","key":"1873_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1009104","volume":"18","author":"GR Howard","year":"2022","unstructured":"Howard GR, Jost TA, Yankeelov TE, Brock A (2022) Quantification of long-term doxorubicin response dynamics in breast cancer cell lines to direct treatment schedules. PLoS Comput Biol 18(3):e1009104","journal-title":"PLoS Comput Biol"},{"issue":"6","key":"1873_CR59","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1472-8206.2008.00633.x","volume":"22","author":"S Goutelle","year":"2008","unstructured":"Goutelle S, Maurin M, Rougier F, Barbaut X, Bourguignon L, Ducher M, Maire P (2008) The Hill equation: a review of its capabilities in pharmacological modelling. Fundam Clin Pharmacol 22(6):633\u2013648","journal-title":"Fundam Clin Pharmacol"},{"issue":"1","key":"1873_CR60","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.1038\/s41467-021-24789-z","volume":"12","author":"DJ Wooten","year":"2021","unstructured":"Wooten DJ, Meyer CT, Lubbock AL, Quaranta V, Lopez CF (2021) MuSyC is a consensus framework that unifies multi-drug synergy metrics for combinatorial drug discovery. Nat Commun 12(1):4607","journal-title":"Nat Commun"},{"issue":"1","key":"1873_CR61","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1146\/annurev-pathol-020712-163923","volume":"8","author":"V Almendro","year":"2013","unstructured":"Almendro V, Marusyk A, Polyak K (2013) Cellular heterogeneity and molecular evolution in cancer. Annu Rev Pathol: Mech Dis 8(1):277\u2013302","journal-title":"Annu Rev Pathol: Mech Dis"},{"issue":"1","key":"1873_CR62","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev-bioeng-071813-105259","volume":"16","author":"RK Jain","year":"2014","unstructured":"Jain RK, Martin JD, Stylianopoulos T (2014) The role of mechanical forces in tumor growth and therapy. Annu Rev Biomed Eng 16(1):321\u2013346","journal-title":"Annu Rev Biomed Eng"},{"issue":"13","key":"1873_CR63","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.1158\/0008-5472.CAN-12-4521","volume":"73","author":"T Stylianopoulos","year":"2013","unstructured":"Stylianopoulos T, Martin JD, Snuderl M, Mpekris F, Jain SR, Jain RK (2013) Coevolution of solid stress and interstitial fluid pressure in tumors during progression: implications for vascular collapse. Cancer Res 73(13):3833\u20133841","journal-title":"Cancer Res"},{"issue":"1","key":"1873_CR64","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1593\/tlo.13748","volume":"7","author":"X Li","year":"2014","unstructured":"Li X, Kang H, Arlinghaus LR, Abramson RG, Chakravarthy AB, Abramson VG, Farley J, Sanders M, Yankeelov TE (2014) Analyzing spatial heterogeneity in DCE- and DW-MRI parametric maps to optimize prediction of pathologic response to neoadjuvant chemotherapy in breast cancer. Trans Oncol 7(1):14\u201322","journal-title":"Trans Oncol"},{"issue":"7","key":"1873_CR65","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.3390\/cancers14071837","volume":"14","author":"AS Kazerouni","year":"2022","unstructured":"Kazerouni AS, Hormuth DA, Davis T, Bloom MJ, Mounho S, Rahman G, Virostko J, Yankeelov TE, Sorace AG (2022) Quantifying tumor heterogeneity via MRI habitats to characterize microenvironmental alterations in HER2+ breast cancer. Cancers 14(7):1837","journal-title":"Cancers"},{"issue":"7","key":"1873_CR66","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/annonc\/mdy127","volume":"29","author":"F Poggio","year":"2018","unstructured":"Poggio F, Bruzzone M, Ceppi M, Pond\u00e9 N, La Valle G, Del Mastro L, de Azambuja E, Lambertini M (2018) Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis. Ann Oncol 29(7):1497\u20131508","journal-title":"Ann Oncol"},{"issue":"9","key":"1873_CR67","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1109\/TMI.2020.2975375","volume":"39","author":"C Wu","year":"2020","unstructured":"Wu C, Hormuth DA, Oliver TA, Pineda F, Lorenzo G, Karczmar GS, Moser RD, Yankeelov TE (2020) Patient-specific characterization of breast cancer hemodynamics using image-guided computational fluid dynamics. IEEE Trans Med Imag 39(9):2760\u20132771","journal-title":"IEEE Trans Med Imag"},{"issue":"2","key":"1873_CR68","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2174\/157340507780619179","volume":"3","author":"TE Yankeelov","year":"2007","unstructured":"Yankeelov TE, Gore JC (2007) Dynamic contrast enhanced magnetic resonance imaging in oncology: theory, data acquisition, analysis, and examples. Curr Med Imaging Rev 3(2):91\u2013107","journal-title":"Curr Med Imaging Rev"},{"issue":"6Part1","key":"1873_CR69","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1118\/1.3414035","volume":"37","author":"X Li","year":"2010","unstructured":"Li X, Dawant BM, Welch EB, Chakravarthy AB, Xu L, Mayer I, Kelley M, Meszoely I, Means-Powell J, Gore JC, Yankeelov TE (2010) Validation of an algorithm for the nonrigid registration of longitudinal breast mr images using realistic phantoms. Med Phys 37(6Part1):2541\u20132552","journal-title":"Med Phys"},{"key":"1873_CR70","doi-asserted-by":"crossref","unstructured":"Tajdari F, Kwa F, Versteegh C, Huysmans T, Song Y (2022) Dynamic 3d mesh reconstruction based on nonrigid iterative closest-farthest points registration. In: International design engineering technical conferences and computers and information in engineering conference, vol 86212, pp V002T02A051. American Society of Mechanical Engineers,","DOI":"10.1115\/DETC2022-90073"},{"key":"1873_CR71","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1109\/TIP.2022.3148822","volume":"31","author":"F Tajdari","year":"2022","unstructured":"Tajdari F, Huysmans T, Yang Y, Song Y (2022) Feature preserving non-rigid iterative weighted closest point and semi-curvature registration. IEEE Trans Image Process 31:1841\u20131856","journal-title":"IEEE Trans Image Process"},{"issue":"6","key":"1873_CR72","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1109\/TMI.2020.2967322","volume":"39","author":"JS Heiselman","year":"2020","unstructured":"Heiselman JS, Jarnagin WR, Miga MI (2020) Intraoperative correction of liver deformation using sparse surface and vascular features via linearized iterative boundary reconstruction. IEEE Trans Med Imaging 39(6):2223\u20132234","journal-title":"IEEE Trans Med Imaging"},{"issue":"17","key":"1873_CR73","doi-asserted-by":"publisher","first-page":"5851","DOI":"10.1088\/0031-9155\/58\/17\/5851","volume":"58","author":"JA Weis","year":"2013","unstructured":"Weis JA, Miga MI, Arlinghaus LR, Li X, Chakravarthy AB, Abramson V, Farley J, Yankeelov TE (2013) A mechanically coupled reaction-diffusion model for predicting the response of breast tumors to neoadjuvant chemotherapy. Phys Med Biol 58(17):5851\u20135866","journal-title":"Phys Med Biol"},{"issue":"22","key":"1873_CR74","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.1158\/0008-5472.CAN-14-2945","volume":"75","author":"JA Weis","year":"2015","unstructured":"Weis JA, Miga MI, Arlinghaus LR, Li X, Abramson V, Chakravarthy AB, Pendyala P, Yankeelov TE (2015) Predicting the response of breast cancer to neoadjuvant therapy using a mechanically coupled reaction-diffusion model. Cancer Res 75(22):4697\u20134707","journal-title":"Cancer Res"},{"key":"1873_CR75","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.cma.2016.08.024","volume":"314","author":"JA Weis","year":"2017","unstructured":"Weis JA, Miga MI, Yankeelov TE (2017) Three-dimensional image-based mechanical modeling for predicting the response of breast cancer to neoadjuvant therapy. Comput Methods Appl Mech Eng 314:494\u2013512","journal-title":"Comput Methods Appl Mech Eng"},{"issue":"6","key":"1873_CR76","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/mrm.23203","volume":"66","author":"NC Atuegwu","year":"2011","unstructured":"Atuegwu NC, Arlinghaus LR, Li X, Welch EB, Chakravarthy AB, Gore JC, Yankeelov TE (2011) Integration of diffusion-weighted MRI data and a simple mathematical model to predict breast tumor cellularity during neoadjuvant chemotherapy. Magn Reson Med 66(6):1689\u20131696","journal-title":"Magn Reson Med"},{"issue":"3","key":"1873_CR77","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1593\/tlo.13130","volume":"6","author":"NC Atuegwu","year":"2013","unstructured":"Atuegwu NC, Arlinghaus LR, Li X, Chakravarthy AB, Abramson VG, Sanders ME, Yankeelov TE (2013) Parameterizing the logistic model of tumor growth by DW-MRI and DCE-MRI data to predict treatment response and changes in breast cancer cellularity during neoadjuvant chemotherapy. Trans. Oncol. 6(3):256\u2013264","journal-title":"Trans. Oncol."},{"issue":"6","key":"1873_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0157368","volume":"11","author":"BD Lehmann","year":"2016","unstructured":"Lehmann BD, Jovanovi\u0107 B, Chen X, Estrada MV, Johnson KN, Shyr Y, Moses HL, Sanders ME, Pietenpol JA (2016) Refinement of triple-negative breast cancer molecular subtypes: implications for neoadjuvant chemotherapy selection. PLoS ONE 11(6):1\u201322","journal-title":"PLoS ONE"},{"issue":"9","key":"1873_CR79","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/nmeth.2138","volume":"9","author":"DR Tyson","year":"2012","unstructured":"Tyson DR, Garbett SP, Frick PL, Quaranta V (2012) Fractional proliferation: a method to deconvolve cell population dynamics from single-cell data. Nat Methods 9(9):923\u2013928","journal-title":"Nat Methods"},{"key":"1873_CR80","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.453","volume":"2","author":"S Van der Walt","year":"2014","unstructured":"Van der Walt S, Sch\u00f6nberger JL, Nunez-Iglesias J, Boulogne F, Warner JD, Yager N, Gouillart E, Yu T (2014) scikit-image: image processing in python. PeerJ 2:e453","journal-title":"PeerJ"},{"issue":"6","key":"1873_CR81","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nmeth.3852","volume":"13","author":"LA Harris","year":"2016","unstructured":"Harris LA, Frick PL, Garbett SP, Hardeman KN, Paudel BB, Lopez CF, Quaranta V, Tyson DR (2016) An unbiased metric of antiproliferative drug effect in vitro. Nat Methods 13(6):497\u2013500","journal-title":"Nat Methods"},{"issue":"W1","key":"1873_CR82","doi-asserted-by":"publisher","first-page":"W633","DOI":"10.1093\/nar\/gkab424","volume":"49","author":"ALR Lubbock","year":"2021","unstructured":"Lubbock ALR, Harris LA, Quaranta V, Tyson DR, Lopez CF (2021) Thunor: visualization and analysis of high-throughput dose-response datasets. Nucleic Acids Res 49(W1):W633\u2013W640","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"1873_CR83","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1109\/TMI.2017.2779811","volume":"37","author":"T Roque","year":"2018","unstructured":"Roque T, Risser L, Kersemans V, Smart S, Allen D, Kinchesh P, Gilchrist S, Gomes AL, Schnabel JA, Chappell MA (2018) A DCE-MRI driven 3-D reaction\u2013diffusion model of solid tumor growth. IEEE Trans Med Imag 37(3):724\u2013732","journal-title":"IEEE Trans Med Imag"},{"issue":"1","key":"1873_CR84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051951","volume":"8","author":"ML Neal","year":"2013","unstructured":"Neal ML, Trister AD, Cloke T, Sodt R, Ahn S, Baldock AL, Bridge CA, Lai A, Cloughesy TF, Mrugala MM, Rockhill JK, Rockne RC, Swanson KR (2013) Discriminating survival outcomes in patients with glioblastoma using a simulation-based, patient-specific response metric. PLoS ONE 8(1):e51951","journal-title":"PLoS ONE"},{"issue":"1","key":"1873_CR85","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1109\/TMI.2020.3024264","volume":"40","author":"K Scheufele","year":"2021","unstructured":"Scheufele K, Subramanian S, Biros G (2021) Fully automatic calibration of tumor-growth models using a single mpMRI scan. IEEE Trans Med Imag 40(1):193\u2013204","journal-title":"IEEE Trans Med Imag"},{"issue":"8","key":"1873_CR86","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/nbt0897-778","volume":"15","author":"G Helmlinger","year":"1997","unstructured":"Helmlinger G, Netti PA, Lichtenbeld HC, Melder RJ, Jain RK (1997) Solid stress inhibits the growth of multicellular tumor spheroids. Nat Biotechnol 15(8):778\u2013783","journal-title":"Nat Biotechnol"},{"key":"1873_CR87","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jmps.2017.12.015","volume":"112","author":"M Fraldi","year":"2018","unstructured":"Fraldi M, Carotenuto AR (2018) Cells competition in tumor growth poroelasticity. J Mech Phys Solids 112:345\u2013367","journal-title":"J Mech Phys Solids"},{"issue":"4","key":"1873_CR88","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1073\/pnas.1815735116","volume":"116","author":"G Lorenzo","year":"2019","unstructured":"Lorenzo G, Hughes TJR, Dominguez-Frojan P, Reali A, Gomez H (2019) Computer simulations suggest that prostate enlargement due to benign prostatic hyperplasia mechanically impedes prostate cancer growth. Proc Natl Acad Sci USA 116(4):1152\u20131161","journal-title":"Proc Natl Acad Sci USA"},{"key":"1873_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.cma.2020.112843","volume":"362","author":"G Lorenzo","year":"2020","unstructured":"Lorenzo G, Hughes T, Reali A, Gomez H (2020) A numerical simulation study of the dual role of 5$$\\alpha$$-reductase inhibitors on tumor growth in prostates enlarged by benign prostatic hyperplasia via stress relaxation and apoptosis upregulation. Comput Methods Appl Mech Eng 362:112843","journal-title":"Comput Methods Appl Mech Eng"},{"issue":"07","key":"1873_CR90","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1142\/S0218202520500220","volume":"30","author":"P Colli","year":"2020","unstructured":"Colli P, Gomez H, Lorenzo G, Marinoschi G, Reali A, Rocca E (2020) Mathematical analysis and simulation study of a phase-field model of prostate cancer growth with chemotherapy and antiangiogenic therapy effects. Math Models Methods Appl Sci 30(07):1253\u20131295","journal-title":"Math Models Methods Appl Sci"},{"issue":"13","key":"1873_CR91","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.1088\/0031-9155\/52\/13\/001","volume":"52","author":"M Kohandel","year":"2007","unstructured":"Kohandel M, Kardar M, Milosevic M, Sivaloganathan S (2007) Dynamics of tumor growth and combination of anti-angiogenic and cytotoxic therapies. Phys Med Biol 52(13):3665","journal-title":"Phys Med Biol"},{"key":"1873_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mbs.2017.02.003","volume":"288","author":"M Bogda\u0144ska","year":"2017","unstructured":"Bogda\u0144ska M, Bodnar M, Belmonte-Beitia J, Murek M, Schucht P, Beck J, P\u00e9rez-Garc\u00eda V (2017) A mathematical model of low grade gliomas treated with temozolomide and its therapeutical implications. Math Biosci 288:1\u201313","journal-title":"Math Biosci"},{"issue":"3","key":"1873_CR93","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3934\/mbe.2009.6.521","volume":"6","author":"P Hinow","year":"2009","unstructured":"Hinow P, Gerlee P, McCawley LJ, Quaranta V, Ciobanu M, Wang S, Graham JM, Ayati BP, Claridge J, Swanson KR, Loveless M, Anderson ARA (2009) A spatial model of tumor-host interaction: application of chemotherapy. Math Biosci Eng 6(3):521\u2013546","journal-title":"Math Biosci Eng"},{"issue":"14","key":"1873_CR94","doi-asserted-by":"publisher","first-page":"4413","DOI":"10.1158\/1078-0432.CCR-19-0006","volume":"25","author":"JB West","year":"2019","unstructured":"West JB, Dinh MN, Brown JS, Zhang J, Anderson AR, Gatenby RA (2019) Multidrug cancer therapy in metastatic castrate-resistant prostate cancer: an evolution-based strategy. Clin Cancer Res 25(14):4413\u20134421","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1873_CR95","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/(SICI)1097-0215(19990129)80:3<413::AID-IJC13>3.0.CO;2-I","volume":"80","author":"W Zoli","year":"1999","unstructured":"Zoli W, Ricotti L, Barzanti F, Dal Susino M, Frassineti GL, Milri C, Casadei Giunchi D, Amadori D (1999) Schedule-dependent interaction of doxorubicin, paclitaxel and gemcitabine in human breast cancer cell lines. Int J Cancer 80(3):413\u2013416","journal-title":"Int J Cancer"},{"issue":"11","key":"1873_CR96","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1002\/cbdv.200590119","volume":"2","author":"C L\u00fcpfert","year":"2005","unstructured":"L\u00fcpfert C, Reichel A (2005) Development and application of physiologically based pharmacokinetic-modeling tools to support drug discovery. Chem Biodivers 2(11):1462\u20131486","journal-title":"Chem Biodivers"},{"key":"1873_CR97","unstructured":"Buxton ILO (2018) Pharmacokinetics: The dynamics of drug absorption, distribution, metabolism, and elimination. In: Brunton LL, Hilal-Dandan R, Knollmann BC (eds) Goodman and Gilman\u2019s the pharmacological basis of therapeutics. McGraw-Hill, 13 edition"},{"issue":"12","key":"1873_CR98","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.2165\/00003088-200746120-00005","volume":"46","author":"M Joerger","year":"2007","unstructured":"Joerger M, Huitema AD, Richel DJ, Dittrich C, Pavlidis N, Briasoulis E, Vermorken JB, Strocchi E, Martoni A, Sorio R et al (2007) Population pharmacokinetics and pharmacodynamics of doxorubicin and cyclophosphamide in breast cancer patients. Clin Pharmacokinet 46(12):1051\u20131068","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"1873_CR99","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1097\/01.ftd.0000177224.19294.92","volume":"27","author":"ME de Jonge","year":"2005","unstructured":"de Jonge ME, Huitema AD, van Dam SM, Rodenhuis S, Beijnen JH (2005) Population pharmacokinetics of cyclophosphamide and its metabolites 4-hydroxycyclophosphamide, 2-dechloroethylcyclophosphamide, and phosphoramide mustard in a high-dose combination with thiotepa and carboplatin. Ther Drug Monit 27(6):756\u2013765","journal-title":"Ther Drug Monit"},{"issue":"21","key":"1873_CR100","doi-asserted-by":"publisher","first-page":"6410","DOI":"10.1158\/1078-0432.CCR-07-0064","volume":"13","author":"M Joerger","year":"2007","unstructured":"Joerger M, Huitema AD, Richel DJ, Dittrich C, Pavlidis N, Briasoulis E, Vermorken JB, Strocchi E, Martoni A, Sorio R, Sleeboom HP, Izquierdo MA, Jodrell DI, Calvert H, Boddy AV, Hollema H, F\u00e9ty R, Van der Vijgh WJ, Hempel G, Chatelut E, Karlsson M, Wilkins J, Tranchand B, Schrijvers AH, Twelves C, Beijnen JH, Schellens JH (2007) Population pharmacokinetics and pharmacodynamics of paclitaxel and carboplatin in ovarian cancer patients: a study by the European Organization for Research and Treatment of Cancer - Pharmacology and Molecular Mechanisms Group and New Drug Development Group. Clin Cancer Res 13(21):6410\u20136418","journal-title":"Clin Cancer Res"},{"issue":"4","key":"1873_CR101","doi-asserted-by":"publisher","first-page":"242","DOI":"10.2165\/00003088-199121040-00002","volume":"21","author":"WJ van der Vijgh","year":"1991","unstructured":"van der Vijgh WJ (1991) Clinical pharmacokinetics of carboplatin. Clin Pharmacokinet 21(4):242\u2013261","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"1873_CR102","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2165\/00003088-198815010-00002","volume":"15","author":"P Speth","year":"1988","unstructured":"Speth P, Van Hoesel Q, Haanen C (1988) Clinical pharmacokinetics of doxorubicin. Clin Pharmacokinet 15(1):15\u201331","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"1873_CR103","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00280-013-2069-1","volume":"71","author":"NE Kontny","year":"2013","unstructured":"Kontny NE, W\u00fcrthwein G, Joachim B, Boddy AV, Krischke M, Fuhr U, Thompson PA, J\u00f6rger M, Schellens JH, Hempel G (2013) Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years. Cancer Chemother Pharmacol 71(3):749\u2013763","journal-title":"Cancer Chemother Pharmacol"},{"issue":"9","key":"1873_CR104","first-page":"1481","volume":"2","author":"LW Anderson","year":"1996","unstructured":"Anderson LW, Chen TL, Colvin OM, Grochow LB, Collins JM, Kennedy MJ, Strong JM (1996) Cyclophosphamide and 4-Hydroxycyclophosphamide\/aldophosphamide kinetics in patients receiving high-dose cyclophosphamide chemotherapy. Clin Cancer Res 2(9):1481\u20131487","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1873_CR105","first-page":"599","volume":"1","author":"T Ohtsu","year":"1995","unstructured":"Ohtsu T, Sasaki Y, Tamura T, Miyata Y, Nakanomyo H, Nishiwaki Y, Saijo N (1995) Clinical pharmacokinetics and pharmacodynamics of paclitaxel: a 3-hour infusion versus a 24-hour infusion. Clin Cancer Res 1(6):599\u2013606","journal-title":"Clin Cancer Res"},{"issue":"5","key":"1873_CR106","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1200\/JCO.1997.15.5.1906","volume":"15","author":"L Gianni","year":"1997","unstructured":"Gianni L, Vigano L, Locatelli A, Capri G, Giani A, Tarenzi E, Bonadonna G (1997) Human pharmacokinetic characterization and in vitro study of the interaction between doxorubicin and paclitaxel in patients with breast cancer. J Clin Oncol 15(5):1906\u20131915","journal-title":"J Clin Oncol"},{"key":"1873_CR107","doi-asserted-by":"crossref","unstructured":"Cottrell JA, Hughes TJR, Bazilevs Y (2009) Isogeometric analysis: toward integration of CAD and FEA. Wiley","DOI":"10.1002\/9780470749081"},{"issue":"2","key":"1873_CR108","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1115\/1.2900803","volume":"60","author":"J Chung","year":"1993","unstructured":"Chung J, Hulbert GM (1993) A time integration algorithm for structural dynamics with improved numerical dissipation: the generalized-$$\\alpha$$ method. J Appl Mech 60(2):371\u2013375","journal-title":"J Appl Mech"},{"issue":"3","key":"1873_CR109","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0045-7825(00)00203-6","volume":"190","author":"KE Jansen","year":"2000","unstructured":"Jansen KE, Whiting CH, Hulbert GM (2000) A generalized-$$\\alpha$$ method for integrating the filtered Navier\u2013Stokes equations with a stabilized finite element method. Comput Methods Appl Mech Eng 190(3):305\u2013319","journal-title":"Comput Methods Appl Mech Eng"},{"issue":"3","key":"1873_CR110","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1137\/0907058","volume":"7","author":"Y Saad","year":"1986","unstructured":"Saad Y, Schultz MH (1986) GMRES: a generalized minimal residual algorithm for solving nonsymmetric linear systems. SIAM J Sci Stat Comput 7(3):856\u2013869","journal-title":"SIAM J Sci Stat Comput"},{"issue":"2","key":"1873_CR111","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.cpc.2009.09.018","volume":"181","author":"A Saltelli","year":"2010","unstructured":"Saltelli A, Annoni P, Azzini I, Campolongo F, Ratto M, Tarantola S (2010) Variance based sensitivity analysis of model output. Design and estimator for the total sensitivity index. Comput Phys Commun 181(2):259\u2013270","journal-title":"Comput Phys Commun"},{"key":"1873_CR112","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.cma.2017.08.009","volume":"327","author":"E Lima","year":"2017","unstructured":"Lima E, Oden J, Wohlmuth B, Shahmoradi A, Hormuth D, Yankeelov T, Scarabosio L, Horger T (2017) Selection and validation of predictive models of radiation effects on tumor growth based on noninvasive imaging data. Comput Methods Appl Mech Eng 327:277\u2013305","journal-title":"Comput Methods Appl Mech Eng"},{"issue":"9","key":"1873_CR113","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1056\/NEJMoa1910549","volume":"382","author":"P Schmid","year":"2020","unstructured":"Schmid P, Cortes J, Pusztai L, McArthur H, K\u00fcmmel S, Bergh J, Denkert C, Park YH, Hui R, Harbeck N et al (2020) Pembrolizumab for early triple-negative breast cancer. N Engl J Med 382(9):810\u2013821","journal-title":"N Engl J Med"},{"issue":"1","key":"1873_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-019-2081-2","volume":"17","author":"N Tsur","year":"2019","unstructured":"Tsur N, Kogan Y, Avizov-Khodak E, Vaeth D, Vogler N, Utikal J, Lotem M, Agur Z (2019) Predicting response to pembrolizumab in metastatic melanoma by a new personalization algorithm. J Transl Med 17(1):1\u201315","journal-title":"J Transl Med"},{"issue":"18","key":"1873_CR115","doi-asserted-by":"publisher","first-page":"eaay6298","DOI":"10.1126\/sciadv.aay6298","volume":"6","author":"JD Butner","year":"2020","unstructured":"Butner JD, Elganainy D, Wang CX, Wang Z, Chen SH, Esnaola NF, Pasqualini R, Arap W, Hong DS, Welsh J et al (2020) Mathematical prediction of clinical outcomes in advanced cancer patients treated with checkpoint inhibitor immunotherapy. Sci Adv 6(18):eaay6298","journal-title":"Sci Adv"},{"key":"1873_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.mbs.2022.108911","volume":"353","author":"KL Liao","year":"2022","unstructured":"Liao KL, Watt KD (2022) Mathematical modeling for the combination treatment of ifn-$$\\gamma$$ and anti-pd-1 in cancer immunotherapy. Math Biosci 353:108911","journal-title":"Math Biosci"},{"issue":"10","key":"1873_CR117","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrc3599","volume":"13","author":"C Holohan","year":"2013","unstructured":"Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG (2013) Cancer drug resistance: an evolving paradigm. Nat Rev Cancer 13(10):714\u2013726","journal-title":"Nat Rev Cancer"},{"key":"1873_CR118","doi-asserted-by":"crossref","unstructured":"Yang EY, Howard GR, Brock A, Yankeelov TE, Lorenzo G (2022) Mathematical characterization of population dynamics in breast cancer cells treated with doxorubicin. Front Mol Biosci 9","DOI":"10.3389\/fmolb.2022.972146"},{"issue":"7","key":"1873_CR119","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/s43018-021-00222-8","volume":"2","author":"C Gutierrez","year":"2021","unstructured":"Gutierrez C, Al\u2019Khafaji AM, Brenner E, Johnson KE, Gohil SH, Lin Z, Knisbacher BA, Durrett RE, Li S, Parvin S et al (2021) Multifunctional barcoding with ClonMapper enables high-resolution study of clonal dynamics during tumor evolution and treatment. Nat. Cancer 2(7):758\u2013772","journal-title":"Nat. Cancer"},{"issue":"11","key":"1873_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105430","volume":"25","author":"G Lorenzo","year":"2022","unstructured":"Lorenzo G, di Muzio N, Deantoni CL, Cozzarini C, Fodor A, Briganti A, Montorsi F, P\u00e9rez-Garc\u00eda VM, Gomez H, Reali A (2022) Patient-specific forecasting of postradiotherapy prostate-specific antigen kinetics enables early prediction of biochemical relapse. Iscience 25(11):105430","journal-title":"Iscience"},{"issue":"1","key":"1873_CR121","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1038\/s41467-020-15424-4","volume":"11","author":"R Brady-Nicholls","year":"2020","unstructured":"Brady-Nicholls R, Nagy JD, Gerke TA, Zhang T, Wang AZ, Zhang J, Gatenby RA, Enderling H (2020) Prostate-specific antigen dynamics predict individual responses to intermittent androgen deprivation. Nat Commun 11(1):1750","journal-title":"Nat Commun"},{"issue":"1","key":"1873_CR122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1745-6150-6-64","volume":"6","author":"EJ Kostelich","year":"2011","unstructured":"Kostelich EJ, Kuang Y, McDaniel JM, Moore NZ, Martirosyan NL, Preul MC (2011) Accurate state estimation from uncertain data and models: an application of data assimilation to mathematical models of human brain tumors. Biol Direct 6(1):1\u201320","journal-title":"Biol Direct"},{"key":"1873_CR123","doi-asserted-by":"crossref","unstructured":"Hormuth DA, Phillips CM, Wu C, Lima EABF, Lorenzo G, Jha PK, Jarrett AM, Oden JT, Yankeelov TE (2021) Biologically-based mathematical modeling of tumor vasculature and angiogenesis via time-resolved imaging data. Cancers 13(12)","DOI":"10.3390\/cancers13123008"},{"issue":"1","key":"1873_CR124","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13014-019-1446-2","volume":"15","author":"DA Hormuth","year":"2020","unstructured":"Hormuth DA, Jarrett AM, Yankeelov TE (2020) Forecasting tumor and vasculature response dynamics to radiation therapy via image based mathematical modeling. Radiat Oncol 15(1):4","journal-title":"Radiat Oncol"},{"key":"1873_CR125","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.cma.2016.07.010","volume":"314","author":"J Xu","year":"2017","unstructured":"Xu J, Vilanova G, Gomez H (2017) Full-scale, three-dimensional simulation of early-stage tumor growth: the onset of malignancy. Comput Methods Appl Mech Eng 314:126\u2013146","journal-title":"Comput Methods Appl Mech Eng"},{"issue":"5","key":"1873_CR126","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0019989","volume":"6","author":"RDM Travasso","year":"2011","unstructured":"Travasso RDM, CorveraPoir\u00e9 E, Castro M, Rodr\u00edguez-Manzaneque JC, Hern\u00e1ndez-Machado A (2011) Tumor angiogenesis and vascular patterning: a mathematical model. PLoS ONE 6(5):1\u201310","journal-title":"PLoS ONE"},{"issue":"24","key":"1873_CR127","doi-asserted-by":"publisher","first-page":"7366","DOI":"10.1158\/0008-5472.CAN-11-1399","volume":"71","author":"KR Swanson","year":"2011","unstructured":"Swanson KR, Rockne RC, Claridge J, Chaplain MA, Alvord J, Ellsworth C, Anderson AR (2011) Quantifying the role of angiogenesis in malignant progression of gliomas: in silico modeling integrates imaging and histology. Cancer Res 71(24):7366\u20137375","journal-title":"Cancer Res"},{"issue":"11","key":"1873_CR128","doi-asserted-by":"publisher","DOI":"10.1002\/cnm.3253","volume":"35","author":"J Kremheller","year":"2019","unstructured":"Kremheller J, Vuong AT, Schrefler BA, Wall WA (2019) An approach for vascular tumor growth based on a hybrid embedded\/homogenized treatment of the vasculature within a multiphase porous medium model. Int J Numer Meth Biomed Eng 35(11):e3253","journal-title":"Int J Numer Meth Biomed Eng"},{"issue":"4","key":"1873_CR129","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1056\/NEJMoa1111097","volume":"366","author":"HD Bear","year":"2012","unstructured":"Bear HD, Tang G, Rastogi P, Geyer CE, Robidoux A, Atkins JN, Baez-Diaz L, Brufsky AM, Mehta RS, Fehrenbacher L, Young JA, Senecal FM, Gaur R, Margolese RG, Adams PT, Gross HM, Costantino JP, Swain SM, Mamounas EP, Wolmark N (2012) Bevacizumab added to neoadjuvant chemotherapy for breast cancer. N Engl J Med 366(4):310\u2013320","journal-title":"N Engl J Med"},{"issue":"07","key":"1873_CR130","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1142\/S0218202521500299","volume":"31","author":"P Colli","year":"2021","unstructured":"Colli P, Gomez H, Lorenzo G, Marinoschi G, Reali A, Rocca E (2021) Optimal control of cytotoxic and antiangiogenic therapies on prostate cancer growth. Math Models Methods Appl Sci 31(07):1419\u20131468","journal-title":"Math Models Methods Appl Sci"},{"key":"1873_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.cma.2021.113975","volume":"384","author":"M Fritz","year":"2021","unstructured":"Fritz M, Jha PK, K\u00f6ppl T, Oden JT, Wagner A, Wohlmuth B (2021) Modeling and simulation of vascular tumors embedded in evolving capillary networks. Comput Methods Appl Mech Eng 384:113975","journal-title":"Comput Methods Appl Mech Eng"},{"issue":"10","key":"1873_CR132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pcbi.1006460","volume":"14","author":"V Vavourakis","year":"2018","unstructured":"Vavourakis V, Stylianopoulos T, Wijeratne PA (2018) In-silico dynamic analysis of cytotoxic drug administration to solid tumours: effect of binding affinity and vessel permeability. PLoS Comput Biol 14(10):1\u201330","journal-title":"PLoS Comput Biol"},{"key":"1873_CR133","doi-asserted-by":"publisher","DOI":"10.1103\/PhysRevLett.125.128103","volume":"125","author":"IF Rizzuti","year":"2020","unstructured":"Rizzuti IF, Mascheroni P, Arcucci S, Ben-M\u00e9riem Z, Prunet A, Barentin C, Rivi\u00e8re C, Delano\u00eb-Ayari H, Hatzikirou H, Guillermet-Guibert J, Delarue M (2020) Mechanical control of cell proliferation increases resistance to chemotherapeutic agents. Phys Rev Lett 125:128103","journal-title":"Phys Rev Lett"},{"issue":"1","key":"1873_CR134","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1038\/s41598-023-30010-6","volume":"13","author":"KP Slavkova","year":"2023","unstructured":"Slavkova KP, Patel SH, Cacini Z, Kazerouni AS, Gardner AL, Yankeelov TE, Hormuth DA (2023) Mathematical modelling of the dynamics of image-informed tumor habitats in a murine model of glioma. Sci Rep 13(1):2916","journal-title":"Sci Rep"},{"issue":"5","key":"1873_CR135","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s43588-021-00069-0","volume":"1","author":"MG Kapteyn","year":"2021","unstructured":"Kapteyn MG, Pretorius JV, Willcox KE (2021) A probabilistic graphical model foundation for enabling predictive digital twins at scale. Nat Comput Sci 1(5):337\u2013347","journal-title":"Nat Comput Sci"},{"issue":"12","key":"1873_CR136","doi-asserted-by":"publisher","DOI":"10.1115\/1.4054925","volume":"144","author":"A Viguerie","year":"2022","unstructured":"Viguerie A, Grave M, Barros GF, Lorenzo G, Reali A, Coutinho A (2022) Data-driven simulation of Fisher\u2013Kolmogorov tumor growth models using dynamic mode decomposition. J Biomech Eng 144(12):121001","journal-title":"J Biomech Eng"},{"key":"1873_CR137","volume-title":"Encyclopedia of computational mechanics","author":"F Chinesta","year":"2016","unstructured":"Chinesta F, Huerta A, Rozza G, Willcox K (2016) Model order reduction. In: Stein E, Borst R, Hughes TJ (eds) Encyclopedia of computational mechanics. Wiley Hoboken, NJ, USA"},{"issue":"2","key":"1873_CR138","doi-asserted-by":"publisher","DOI":"10.1063\/5.0086789","volume":"3","author":"C Wu","year":"2022","unstructured":"Wu C, Lorenzo G, Hormuth DA, Lima EABF, Slavkova KP, DiCarlo JC, Virostko J, Phillips CM, Patt D, Chung C, Yankeelov TE (2022) Integrating mechanism-based modeling with biomedical imaging to build practical digital twins for clinical oncology. Biophys Rev 3(2):021304","journal-title":"Biophys Rev"},{"issue":"5","key":"1873_CR139","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s43588-021-00072-5","volume":"1","author":"SA Niederer","year":"2021","unstructured":"Niederer SA, Sacks MS, Girolami M, Willcox K (2021) Scaling digital twins from the artisanal to the industrial. Nat Comput Sci 1(5):313\u2013320","journal-title":"Nat Comput Sci"}],"container-title":["Engineering with Computers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00366-023-01873-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00366-023-01873-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00366-023-01873-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T15:04:45Z","timestamp":1732892685000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00366-023-01873-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,7]]},"references-count":139,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1873"],"URL":"https:\/\/doi.org\/10.1007\/s00366-023-01873-0","relation":{},"ISSN":["0177-0667","1435-5663"],"issn-type":[{"value":"0177-0667","type":"print"},{"value":"1435-5663","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,7]]},"assertion":[{"value":"15 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"VQ and CTM are co-founders of Duet BioSystems, Inc. The rest of the authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}